These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36466830)

  • 21. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome.
    Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Mantelli F; Allegretti M; Balk RA
    Front Pharmacol; 2021; 12():808797. PubMed ID: 35095519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
    Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
    Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.
    Rudiansyah M; Jasim SA; Mohammad Pour ZG; Athar SS; Jeda AS; Doewes RI; Jalil AT; Bokov DO; Mustafa YF; Noroozbeygi M; Karampoor S; Mirzaei R
    J Med Virol; 2022 Oct; 94(10):4611-4627. PubMed ID: 35689351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.
    Girona J; Rodríguez-Borjabad C; Ibarretxe D; Vallvé JC; Ferré R; Heras M; Rodríguez-Calvo R; Guaita-Esteruelas S; Martínez-Micaelo N; Plana N; Masana L
    J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31717752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective.
    Al-Kuraishy HM; Al-Gareeb AI; Jalal NA; Kabrah SM; Alexiou A; Batiha GE
    Curr Protein Pept Sci; 2022; 23(7):465-474. PubMed ID: 35959625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective.
    Elgohary AM; Elfiky AA; Barakat K
    Comput Biol Med; 2021 Dec; 139():104956. PubMed ID: 34695683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 infection: an overview on cytokine storm and related interventions.
    Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
    Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammasome formation in the lungs of patients with fatal COVID-19.
    Toldo S; Bussani R; Nuzzi V; Bonaventura A; Mauro AG; Cannatà A; Pillappa R; Sinagra G; Nana-Sinkam P; Sime P; Abbate A
    Inflamm Res; 2021 Jan; 70(1):7-10. PubMed ID: 33079210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome.
    Chabert C; Vitte AL; Iuso D; Chuffart F; Trocme C; Buisson M; Poignard P; Lardinois B; Debois R; Rousseaux S; Pepin JL; Martinot JB; Khochbin S
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous sulforhodamine B reduces alveolar surface tension, improves oxygenation, and reduces ventilation injury in a respiratory distress model.
    Wu Y; Nguyen TL; Perlman CE
    J Appl Physiol (1985); 2021 May; 130(5):1305-1316. PubMed ID: 33211596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROS-independent Nrf2 activation in prostate cancer.
    Bellezza I; Scarpelli P; Pizzo SV; Grottelli S; Costanzi E; Minelli A
    Oncotarget; 2017 Sep; 8(40):67506-67518. PubMed ID: 28978049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
    Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
    Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
    Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
    Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients.
    Cervantes-Alvarez E; la Rosa NL; la Mora MS; Valdez-Sandoval P; Palacios-Jimenez M; Rodriguez-Alvarez F; Vera-Maldonado BI; Aguirre-Aguilar E; Escobar-Valderrama JM; Alanis-Mendizabal J; Méndez-Guerrero O; Tejeda-Dominguez F; Torres-Ruíz J; Gómez-Martín D; Colborn KL; Kershenobich D; Huang CA; Navarro-Alvarez N
    Sci Rep; 2022 Feb; 12(1):1856. PubMed ID: 35115644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDS.
    Lo HY; Cheng SP; Huang JL; Chang KT; Chang YL; Huang CH; Chang CJ; Chiu CH; Chen-Yang YW; Chan CK
    Cell Transplant; 2021; 30():9636897211054481. PubMed ID: 34757857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19.
    Ball L; Silva PL; Giacobbe DR; Bassetti M; Zubieta-Calleja GR; Rocco PRM; Pelosi P
    Expert Rev Respir Med; 2022 Apr; 16(4):437-446. PubMed ID: 35341424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
    Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
    Front Immunol; 2022; 13():893792. PubMed ID: 35812400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.